In Vivo Toxicology Market is expected to reach USD 6.6 billion by 2025 with CAGR of 5.5%

 According to the new market research report "In Vivo Toxicology Market by Product (Animal Models, Reagents & Kits), Test Type (Chronic, Sub-acute), Toxicity Endpoints (Systemic, Immunotoxicity), Testing Facility (Outsourced, In-house), End User (Academic & Research Institute, CROs) - Forecast to 2025", is projected to reach USD 6.6 billion by 2025, at a CAGR of 5.5% between 2020 and 2025.



Key Players:

Charles River Laboratories (US), The Jackson Laboratory (US),Envigo (US), Taconic Biosciences, Inc. (US), and JANVIER LABS (France), Thermo Fisher Scientific (US), Danaher Corporation (US), Waters Corporation (US), Agilent Technologies (US), Shimadzu Corporation (Japan), Bruker Corporation (US), PerkinElmer (US). Other prominent players includeMerck KGaA (Germany), GE Healthcare (US), and Bio-Rad Laboratories (US), genOway (France), Cyagen Biosciences (US), GVK BIO (India), PolyGene (Switzerland), Crown Biosciences (US), TransCurebioServices (France), Ozgene Pty Ltd. (Australia), Harbour BioMed (US) among others.

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=105308811

Browse in-depth TOC on "In Vivo Toxicology Market"

305- Tables

40- Figures

276- Pages

The Market growth is driven largely by the increasing R&D activities in the pharmaceutical industry, growing focus and demand for personalized medicine, focus on innovations in animal models, and the development of exclusive tests of in vivo toxicology.

On the basis of product, the in vivo toxicology market is segmented into consumables and instruments. The consumables segment is further divided into animal models and reagents & kits. Animal models is sub segmented into rat, mice, and other animals. In 2019,the consumables segment dominated the market with maximum share of the market. Factors such as increasing use of reagents & kits in research activities, growing funds for research projects, and their extensive application in the in vivo toxicology studies are driving the growth of this segment.

On the basis of test type, the global in vivo toxicology market is categorized into acute, sub-acute, sub-chronic, and chronic test type. The chronic test type segment is expected to dominate the market during the forecast period. The chronic test type segment held the largest share of the market, followed by sub-chronic test type in 2019. Factors such as growing research on drugs used for longer duration therapy such as anti-convulsive, anti-cancer, anti- hypertensives, and anti-arthritis, drives the growth of the chronic test type market.

Request Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=105308811

On the basis of the testing facility, the global in vivo toxicology market is divided into in-house testing facilities and outsourced testing facilities. The outsourced testing facilities segment is expected for largest share in the market, by testing facility, over the forecast period. Factors such as growing research and development investments and strategies in pharmaceutical, biopharmaceutical, and medical devices companies, resulting in increased outsourcing of services to CROs and thus drive the market.

On the basis on the end user, the global in vivo toxicology market has been broadly categorized into academic &research institutes, pharmaceutical & biotechnology companies, contract research organizations, and other end users (cosmetic companies and food laboratories). In 2019, the academic and research institutes segment accounted for the largest share of the market. Factors such as, growing number of research activities and funding in the field of in vivo toxicology to the academic and research institutes to conduct in vivo toxicology research are driving the market.

Buy Now:

https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=105308811

Geographical Growth Scenario:

The global in vivo toxicology market is divided into North America, Europe, the Asia Pacific, Latin America and Middle East & Africa. North America accounted for the largest share of the In Vivo Toxicology Market in 2019. Factors such as increasing biomedical research and preclinical activities by CROs and companies. Additionally, geographic presence of major players operating in the market in the US, drives the market in North America.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: 1-888-600-6441

Email: sales@marketsandmarkets.com

Related Reports:

Contract Research Organization Service Market:

https://www.marketsandmarkets.com/Market-Reports/contract-research-organization-service-market-167410116.html

In-Vitro Toxicology Testing-Market:

https://www.marketsandmarkets.com/Market-Reports/in-vitro-toxicology-testing-market-209577065.html

Rat Model Market:

https://www.marketsandmarkets.com/Market-Reports/rat-model-market-76036494.html

Comments

Post a Comment

Popular posts from this blog

Urology Devices Industry worth $48.6 billion by 2028

 The global urology devices market , valued at US$32.6 billion in 2022, is forecasted to grow at a robust CAGR of 7.3%, reaching US$34.1 billion in 2023 and an impressive US$48.6 billion by 2028. Investments by hospitals in procuring advanced instruments, expanding units, and establishing new centers are expected to boost the market for urology devices. Moreover, increased demand for MIS robotic systems is expected to increase in the coming years, which is expected to propel the market growth. Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173062212 Browse in-depth TOC on “Urology Devices Market” 159 — Tables 44 — Figures 274 — Pages In 2022, the instruments segment held the largest share of the urology devices market by product segment. The urology devices market is segmented into instruments and consumables & accessories based on products. The instruments segment accounted for the largest share of the urology devices market in 2022....
Read more

Healthcare Simulation Market worth $4.6 billion by 2028

Image
The global healthcare simulation market is projected to reach USD 4.6 billion by 2028 from USD 2.2 billion in 2023, at a high CAGR of 15.7% during the forecast period. The market's expansion is fuelled by an advancement in technology, such as high-fidelity manikins and virtual reality that have enhanced the realism and effectiveness of simulation training, for instance, high-fidelity simulators like Apollo (by Elevate Healthcare (formerly CAE)) and Nursing Anne Simulator (by Laerdal Medical) accelerates learning, reduces training time, and improves debriefing with automated patient responses; the growing complexity of modern medical procedures which requires training solutions offered by simulation. Further, the increasing number of medical schools is also propelling this market. For instance, according to Ministry of Health and Family Welfare, in India, the number of medical colleges has risen by 82%, from 387 before 2014 to 706 for the year 2024. Healthcare Simulation Market – G...
Read more

Bronchoscopy Market Size Worth USD 3.7 billion By 2027 | CAGR: 7.9%: MarketsandMarkets™

Image
 The report " Bronchoscopy Market by Product Bronchoscopes (Flexible, Rigid, EBUS), Imaging Systems (Video Processors), Accessories (Cytology Brushes), Application (Bronchial Treatment), Usability (Reusable), & End Users (Hospital, ACSs/Clinic)- Global Forecast to 2027", is projected to reach USD 3.7 billion by 2027 from USD 2.5 billion in 2022, at a CAGR of 7.9% during the forecasted period (2022 to 2027). Browse in-depth TOC on " Bronchoscopy Market" 301- Tables 48- Figures 289- Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=40057877 The growth in this market growth is largely driven by the rising prevalence of respiratory diseases, the growing demand for minimally invasive surgeries, growing hospital investments in bronchoscopy facilities, and technological advancements in bronchoscopes. On the other hand, the dearth of trained physicians and pulmonologists is a major challenge to the growth of this market...
Read more